Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of CLP, with and without
spironolactone, on serum, urine, and fecal contents in heart failure patients with chronic
kidney disease.